Results 71 to 80 of about 3,841 (191)
Diagnosis of bone metastasis in patients with non-small cell lung cancer by combined detection of CEA, CYFRA21-1, and ALP [PDF]
Vojnosanitetski PregledBackground/Aim. Despite significant advances in the diagnosis and treatment of non-small cell lung cancer (NSCLC), the overall prognosis remains poor, especially when bone metastasis occurs with disease progression.
Ye Haiying, Zhang Qiaoli
doaj +1 more source
Cyfra 21-1 as a serum tumor marker for follow up of patients with laryngeal and hypopharyngeal squamous cell carcinoma [PDF]
, 2009 AIM: To evaluate the importance and potential of Cyfra21-1 as a tumor marker (TM) for follow-up of patients with squamous cell carcinoma (SCC) in laryngeal and hypopharyngeal cancer.
Al-Shagahin, Hani
core +1 more source
Interdisciplinary Medicine, Volume 4, Issue 1, January 2026.This review systematically summarizes recent advances in aggregation‐induced emission (AIE) materials for in vitro diagnostics (IVD). It highlights probe design strategies—categorizing them into direct‐responsive, indirect‐responsive, and nano‐immunoprobes—and their applications in detecting a wide range of biomarkers across diverse body fluids ...
Qi Liu +5 more
wiley +1 more source
CYFRA21-1和CEA对Ⅲ期非小细胞肺癌患者的临床预后意义
Zhongguo shiyan zhenduanxue, 2007 目的探讨CYFRA21-1和CEA对Ⅲ期非小细胞肺癌患者的临床预后意义。方法采用化学发光法检测62例Ⅲ期非小细胞肺癌患者放疗前与放疗结束时血清标本中CYFRA21-1和CEA的含量,临床随访6-24月。结果Ⅲ期非小细胞肺癌患者放疗结束时血清中CYFRA21-1和CEA的水平显著低于放疗前;放疗前血清中CYFRA21-1和CEA升高患者组的2年生存率与正常组2年生存率差异均无显著性意义;放疗结束时CYFRA21-1和CEA的水平正常组的两年生存率明显高于升高组;放疗结束时CYFRA21 ...
邓湘, 修霞, 谭爱国
doaj
Nanotechnology‐Enhanced Approaches for Early Cancer Diagnosis
Nano Select, Volume 7, Issue 1, January 2026.Conventional MRI and PET provide limited sensitivity and contrast for precise brain lesion detection. In contrast, radiolabeled nanoparticlebased PET imaging enables enhanced signal specificity and sensitivity. By integrating multifunctional nanoprobes, this platform improves multimodal imaging performance, allowing more accurate visualization of ...
Jongmoo Lee +5 more
wiley +1 more source
Five years of advances in electrochemical analysis of protein biomarkers in lung cancer: a systematic review [PDF]
Lung cancer is the leading cause of cancer death in both men and women. It represents a public health problem that must be addressed through the early detection of specific biomarkers and effective treatment.
Alcázar-Navarrete, Bernardino +7 more
core +4 more sources
Small, Volume 22, Issue 1, 2 January 2026.This study presents a facile method to fabricate focal volume‐comparable and uniform 3D architectures of plasmonic hotspots by devising force‐assisted, capillary‐mediated stacking of colloidal metal nanoparticles for ultrasensitive molecular detections.
Ju A. La +10 more
wiley +1 more source
Distinction of ALK fusion gene‐ and EGFR mutation‐positive lung cancer with tumor markers
Thoracic CancerBackground It is difficult to predict gene mutations individually based on clinical background alone. Tumor markers may help to predict each gene mutation.
Takahiro Akita +11 more
doaj +1 more source
Chinese Journal of Lung Cancer, 2016 Background and objective Due to it's concealment and no obvious symptoms, lung squamous carcimoma often has advanced disease when diagnosed. The aims of this study were to describe the characteristics of the disease, to evaluate the clinical importance ...
Ping LIANG, Junling LI
doaj +1 more source
The Clinical Respiratory Journal, Volume 20, Issue 1, January 2026.Our manuscript presents detailed presentations of case series of thoracic SMARCA4‐UT, and we report a unique case of diaphragmatic metastases and, interestingly, the occurrence of brain metastasis in one patient, which is a rare phenomenon in SMARCA4‐UT.
Fangzhen Shan +12 more
wiley +1 more source